APOB and steatosis: In MAFLD patients with type 2 diabetes, triglycerides had a dose–response relationship with moderate-to-severe steatosis in the multivariable-adjusted model (p for trend = 0.049), as did ApoB in the crude model (p for trend = 0.025).